Kolexia
Blin Nicolas Hématologie
Blin Nicolas
Hématologie
Hôpital Hôtel-Dieu Nantes
Nantes, France
204 Activités
773 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Myélome multiple Leucémie-lymphome lymphoblastique à précurseurs B et T Maladie du greffon contre l'hôte Tumeurs hématologiques Leucémie aigüe myéloïde Leucémie myéloïde Lymphome B

Collaborateurs

Voir plus
Moreau Philippe
Moreau Philippe
Hôpital Hôtel-Dieu Nantes, Nantes, France
Mahe Beatrice
Mahe Beatrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Dubruille Viviane
Dubruille Viviane
Hôpital Hôtel-Dieu Nantes, Nantes, France
Gastinne Thomas
Gastinne Thomas
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
A+A
628 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
437 collaboration(s)
Dernière en 2023
P\S\L Group Services
184 collaboration(s)
Dernière en 2023
B3TSI
171 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
American journal of hematology   02 janvier 2024
Impact of Ethnicity in Treatment Choice for Multiple Myeloma in the 3 First Lines of Therapy: Data from Observational Retrospective Real-World Study in the USA
65th ASH Annual Meeting Abstracts   02 novembre 2023
Main Treatment Choices in the 2 First Lines of Therapy for Multiple Myeloma in Patients with High Risk Cytogenetics: Lesson from the Real World in the EU5 Countries and the USA
65th ASH Annual Meeting Abstracts   02 novembre 2023
Quad-class exposed/refractory myeloma is associated with short survival.
British journal of haematology   13 octobre 2023
HILDEGAZ: Phase 1 Dose Escalation of Early Infusion of Zoledronic Acid in Combination With Increasing Low-dose of Interleukin-2 in Order to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allogeneic Stem Cell Transplantation (SCT)
Essai Clinique (CHU Nantes)   05 octobre 2023
HPN : Nouveaux concepts / changements dans la prise en charge des patients
Edimark   15 juin 2023
Post-CAR T-Cell Early Reconstitution of Peripheral T-Cell Subsets Is Heterogeneous and Independent of the Cell Therapy Outcome in High Grade B-Cell Lymphoma
Annual Meeting Abstracts 2022   15 novembre 2022
Biological Differences between Axi-Cel and Tisa-Cel Products and Impacts on Outcomes in Lymphoma Patients
Annual Meeting Abstracts 2022   15 novembre 2022
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
Journal of cancer research and clinical oncology   04 mai 2022
IPPACTTO: Pharmaceutical Intervention in the Coordinated Care Pathway for Cancer Patients Treated With Oral Therapy
Essai Clinique (Institut Cancerologie de l'Ouest)   21 avril 2022